Rable piperine dose (50 mg/day) in humans [48]. However, extensive studies are needed to determine the optimal tolerable dose of piperine in preclinical studies before advancing to human trials. Taken together, our findings suggest that caspase-3 activation, PARP-1 cleavage, down-regulation of phosphorylated STAT-3, inhibition of NF-kB expression and AR may represent the molecular mechanism by …
Continue reading “Rable piperine dose (50 mg/day) in humans [48]. However, extensive studies are”